Navigation Links
Amgen Resolves G-CSF Patent Litigation With Teva
Date:7/15/2011

THOUSAND OAKS, Calif., July 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that the United States (U.S.) District Court in Pennsylvania has entered final judgment and a permanent injunction against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA prohibiting them from infringing Amgen's patents relating to human G-CSF (granulocyte colony-stimulating factor) and methods for its use. Today's judgment was accompanied by Teva's admission that its Neutroval™ product infringes the two Amgen patents at issue in the litigation and that those patents are valid and enforceable.  The Court's injunction extends until Nov. 10, 2013, after which date Teva may sell Neutroval in the U.S.  Regarding Neugranin™, another Teva G-CSF product, Teva agrees not to sell Neugranin until Nov. 10, 2013 unless it first obtains a final court decision that Amgen's patents are not infringed by Neugranin. Pursuant to the parties' agreement, the launch date for either product could be sooner if certain unexpected events occur: a third party launches a similar G-CSF product and Amgen fails to sue that third party, or the patents are held invalid or unenforceable in a final court decision in an action brought by a third party. The settlement terms do not include any financial payments between the parties. The two patents at issue in the litigation, U.S. Patent Nos. 5,580,755 and 5,582,823, expire in early December 2013.

"We are very pleased with this outcome, as it reaffirms the validity of these important patents," said David J. Scott, senior vice president, general counsel and secretary at Amgen. "This closes this matter and allows Amgen to continue to focus on bringing innovative therapies to patients with grievous illnesses."

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnol
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss
2. Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
3. Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence
4. Amgen Announces Voting Results Of Annual Meeting of Stockholders
5. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
6. Amgen Oncology Data to be Presented at ASCO Annual Meeting
7. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
8. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
9. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
10. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
11. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... development of therapeutic antibodies, today announced the appointment ... Development Officer. Dr. Londei will lead the preclinical ... "We are pleased to welcome ... Hamza Suria , President and Chief Executive ...
(Date:10/20/2014)... , Oct. 20, 2014   Mary,s Medicinals ... Caring, is a 4-Star Sponsor of Operation Grow4Vets ... with unique products, programs and services to assist them ... Key Facts: , An ever-increasing ... a safe and effective treatment for pain, Post-traumatic Stress ...
(Date:10/19/2014)... Wash. , Oct. 20, 2014 CTI ... that it will report its third quarter 2014 financial ... of the U.S. financial markets. Following the announcement, members ... call to discuss the results and provide a general ... Access to the event can be obtained as follows: ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2
... N.J., Dec. 23, 2010 Dey Pharma, L.P. today ... Meda, a leading international specialty pharma company headquartered in ... EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen Auto-Injector is used ... can occur quickly, often within a couple of minutes, ...
... Partners announced today that it has updated coverage on ... ) ("the Company") and maintains its twelve month target price ... "DAVANAT®, the Company,s lead product candidate, could potentially enhance the ... , while also reducing the side effect profile of these ...
Cached Medicine Technology:Mylan's Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe 2Mylan's Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe 3Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10 2
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... October 20, 2014 National Teen Driver Safety ... the American Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) ... encouraging parents of teen drivers to talk to their teens ... , Motor vehicle crashes are the leading cause of death ... involved in fatal crashes, and 859 (42%) of those teen ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, ... estimates member hospital ROI on membership dues at 12.5. In ... provides $12.50 in value to member hospitals. The calculation used ... Dues)/Member Dues. , “This is the first time we’ve ... think the methodology is really sound,” said Bill Ryan ...
(Date:10/20/2014)... 20, 2014 Punzoné , the first ... U.S., has a lot to celebrate this month. October marks ... the achievements and contributions of Americans of Italian heritage and ... and today it shares its favorite Italian cocktails and encourages ... Italy - even if it is only in a glass. ...
(Date:10/20/2014)... 2014 Do you ever feel difficulty ... a wonderful app Metassessor for teachers, specialists and parents. ... helped its client “Intervention Development LLC” to launch Metassessor ... designed for iOS 4.3 or later and is Compatible ... optimized for iPhone 5. It is now available on ...
Breaking Medicine News(10 mins):Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... regulating cholesterol in the bloodstream also appears to affect progesterone ... substantial number of cases of their infertility, a new study ... has also developed a simple blood test for this variation ... but emphasized there is no approved therapy yet to address ...
... 2011)Today,s anticancer drugs often work wonders against malignancies, but ... drugs, and treatment fails. Medical researchers would like to ... must understand why and how it happens. New findings ... Abcc10 (also known as Mrp7), as being intimately involved ...
... Critical new research has found that lesbian, gay, bisexual, ... school victimization in middle and high school report impaired ... suicide attempts that require medical care, sexually transmitted diseases ... known study to examine the relationship between school victimization ...
... with advanced prostate cancer suggest they can be good ... study found a 20-year survival rate for 80 percent ... beyond the prostate, known as cT3 prostate cancer, and ... prostate gland. Previously, patients found to have cT3 prostate ...
... DENVER Continuous positive airway pressure (CPAP) effectively decreases ... suffer from obstructive sleep apnea (OSA), according to a ... the first large-scale study to assess the impact of ... mortality in the elderly. The findings will be ...
... Patients with small kidney tumors are more likely ... volume and type of practice than on tumor characteristics, ... practice in academic medical centers with high volumes of ... more likely to follow American Urological Association (AUA) guidelines ...
Cached Medicine News:Health News:Gene variation linked to infertility in women, study finds 2Health News:Gene variation linked to infertility in women, study finds 3Health News:Abcc10 may be effective in extending the effectiveness of anticancer drugs 2Health News:Abcc10 may be effective in extending the effectiveness of anticancer drugs 3Health News:School bullying, violence against LGBT youth linked to risk of suicide, HIV infection 2Health News:School bullying, violence against LGBT youth linked to risk of suicide, HIV infection 3Health News:CPAP decreases cardiovascular mortality in elderly patients 2Health News:CPAP decreases cardiovascular mortality in elderly patients 3
... The Equalizer With 384 Well Plate ... the revolutionary features of the original Equalizerexpandable and ... autoclavable components, and in-lab calibration capabilities. In addition, ... tips down to 4.5mm for loading and accessing ...
... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...
... Tip System A lower cost alternative to ... perform multi-sample transfers between two different vessel configurations. ... tip spacing can be quickly and easily adjusted ... well plates. Ergonomic Design for Unparalleled Comfort ...
... Tip System A lower cost alternative to ... perform multi-sample transfers between two different vessel configurations. ... tip spacing can be quickly and easily adjusted ... well plates. Ergonomic Design for Unparalleled Comfort ...
Medicine Products: